ResMed Inc. (0KW4)
LSE
232.31
+0.28 (+0.12%)
Real-time Data
07:00 AM
Day's Range
228.01233.00
52 wk Range
180.60297.98
Financial Statements - 0KW4 - ResMed Inc.
Revenue
69.53B▲ 2.1%
Net Income
179.79M▲ 127.6%Net Margin 0.3%
EBITDA
4.73B▼ 3.5%
Free Cash Flow
2.86B▲ 5.0%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 69.53B | 68.07B | 69.87B | 58.40B |
| Cost of Goods | 64.52B | 62.60B | 63.69B | 53.32B |
| Gross Profit | 5.01B | 5.46B | 6.17B | 5.08B |
 Operating Expense | - | - | - | - |
| Operating Income | 1.10B | 1.52B | 2.03B | 1.30B |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 490.52M | 348.05M | 1.35B | 515.63M |
| Income Tax | 310.73M | 269.07M | 441.52M | 373.58M |
| Net Income | 179.79M | 78.97M | 914.24M | 142.05M |
| EPS Basic | 0.009 | 0.004 | 0.048 | 0.008 |
| EPS Diluted | 0.009 | 0.004 | 0.048 | 0.008 |
| Basic Shares Outstanding | 19.97B | 19.74B | 19.04B | 17.75B |
| Diluted Shares Outstanding | 19.97B | 19.74B | 19.04B | 17.75B |
| Ebit | - | - | - | - |
| Ebitda | 4.73B | 4.90B | 5.72B | 4.35B |
| Net Income Continuous Operations | 179.79M | 78.97M | 914.24M | 142.05M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
